Characterising Lipid Lipolysis and Its Implication in Lipid-Based Formulation Development

Journal Title: The AAPS Journal - Year 2012, Vol 14, Issue 4

Abstract

Facing the increasing number of poorly water-soluble drugs, pharmaceutical scientists are required to break new grounds for the delivery of these pharmaceutically problematic drugs. Lipid-based drug delivery systems (LBDDS) have received increased interest as a novel drug delivery platform during the last decades and several successfully marketed products have shown the potential for LBDDS. However, there exists a discrepancy between the clear need for innovative delivery forms and their rational design. In the case of LBDDS, this can be attributed to the complexity of LBDDS after administration. Unlike conventional formulations, LBDDS are susceptible to digestion in the gastrointestinal tract, the interplay of delivery system, drug and physiology ultimately effecting drug disposition. In vitro lipolysis has become an important technique to mimic the enzymatic degradation. For the better understanding of how LBDDS promote drug delivery, in vitro lipolysis requires advanced characterisation methods. In this review, the physiological background of lipid digestion is followed by a thorough summary of the techniques that are currently used to characterise in vitro lipolysis. It would be desirable that the increasing knowledge about LBDDS will foster their rationale development thereby increasing their broader application.

Authors and Affiliations

Nicky Thomas, René Holm, Thomas Rades, Anette Müllertz

Keywords

Related Articles

Next Generation Ligand Binding Assays—Review of Emerging Real-Time Measurement Technologies

Over the last few years, numerous ligand binding assay technologies that utilize real-time measurement have been introduced; however, an assemblage and evaluation of these technologies has not previously been published....

Effects of Selected OATP and/or ABC Transporter Inhibitors on the Brain and Whole-Body Distribution of Glyburide

Glyburide (glibenclamide, GLB) is a widely prescribed antidiabetic with potential beneficial effects in central nervous system injury and diseases. In vitro studies show that GLB is a substrate of organic anion transport...

Determination of the Dominant Arachidonic Acid Cytochrome P450 Monooxygenases in Rat Heart, Lung, Kidney, and Liver: Protein Expression and Metabolite Kinetics

Cytochrome P450 (P450)-derived arachidonic acid (AA) metabolites serve pivotal physiological roles. Therefore, it is important to determine the dominant P450 AA monooxygenases in different organs. We investigated the P45...

Impact-Insertion Applicator Improves Reliability of Skin Penetration by Solid Microneedle Arrays

In this study, high-density arrays (576 microneedles on a 5 × 5-mm backplate, gifted by Bosch, Germany, Stuttgart) with a microneedle length of 200 μm were used (Fig. 1 )....

AIDS Treatment with Novel Anti-HIV Compounds Improved by Nanotechnology

The first International Symposium of Nanomedicine on AIDS “AIDS Treatment with Novel Anti-HIV compounds Improved by Nanotechnology” was held November 19–20, 2009 in Beijing, China. This symposium...

Download PDF file
  • EP ID EP681279
  • DOI  10.1208/s12248-012-9398-6
  • Views 85
  • Downloads 0

How To Cite

Nicky Thomas, René Holm, Thomas Rades, Anette Müllertz (2012). Characterising Lipid Lipolysis and Its Implication in Lipid-Based Formulation Development. The AAPS Journal, 14(4), -. https://europub.co.uk/articles/-A-681279